You are required to be logged in to access the full website
Click here if you have forgotten your username or password
18 June 2021 - - The US Food and Drug Administration has accepted US-based biotechnology company Xilio Therapeutics' Investigational New Drug application to evaluate its checkpoint inhibitor product candidate, XTX101, as a potential treatment fo...
18 June 2021 - - US-based biopharmaceutical company Immunome, Inc. (NASDAQ: IMNM) has appointed Franklyn G. Prendergast, M.D., Ph.D., to its board of directors, the company said.
Dr. Prendergast is a renowned medical and academic researc...
Dr. Prendergast is a renowned medical and academic researc...
18 June 2021 - - US-based biotechnology company Pinteon Therapeutics has received a USD 3m award from Advanced Technology International to support the company's Phase 1 study of PNT001 in hospitalized patients with acute traumatic brain injury, ...
18 June 2021 - - US-based ophthalmic pharmaceutical company Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has completed patient enrollment for its first Phase 3 clinical trial of netarsudil ophthalmic solution in Japan, comparing netarsudil ophthalmic s...
18 June 2021 - - Japan-based pharmaceutical company Eisai Co., Ltd. and US-based Bristol-Myers Squibb Company (NYSE: BMY) have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercializatio...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe